Your browser doesn't support javascript.
loading
Erratum: Author correction to 'Real-time SERS monitoring anticancer drug release along with SERS/MR imaging for pH-sensitive chemo-phototherapy' [Acta Pharm Sin B 13 (2023) 1303-1317].
Huang, Xueqin; Sheng, Bingbing; Tian, Hemi; Chen, Qiuxia; Yang, Yingqi; Bui, Brian; Pi, Jiang; Cai, Huaihong; Chen, Shanze; Zhang, Jianglin; Chen, Wei; Zhou, Haibo; Sun, Pinghua.
Afiliación
  • Huang X; The Second Clinical Medical College (Shenzhen People's Hospital), College of Pharmacy, Jinan University, Guangzhou 510632, China.
  • Sheng B; The Second Clinical Medical College (Shenzhen People's Hospital), College of Pharmacy, Jinan University, Guangzhou 510632, China.
  • Tian H; The Second Clinical Medical College (Shenzhen People's Hospital), College of Pharmacy, Jinan University, Guangzhou 510632, China.
  • Chen Q; The Second Clinical Medical College (Shenzhen People's Hospital), College of Pharmacy, Jinan University, Guangzhou 510632, China.
  • Yang Y; The Second Clinical Medical College (Shenzhen People's Hospital), College of Pharmacy, Jinan University, Guangzhou 510632, China.
  • Bui B; Department of Physics, the University of Texas at Arlington, Arlington, TX 76019, USA.
  • Pi J; Department of Chemistry, Jinan University, Guangzhou 510632, China.
  • Cai H; Department of Chemistry, Jinan University, Guangzhou 510632, China.
  • Chen S; The Second Clinical Medical College (Shenzhen People's Hospital), College of Pharmacy, Jinan University, Guangzhou 510632, China.
  • Zhang J; The Second Clinical Medical College (Shenzhen People's Hospital), College of Pharmacy, Jinan University, Guangzhou 510632, China.
  • Chen W; Department of Physics, the University of Texas at Arlington, Arlington, TX 76019, USA.
  • Zhou H; The Second Clinical Medical College (Shenzhen People's Hospital), College of Pharmacy, Jinan University, Guangzhou 510632, China.
  • Sun P; The Second Clinical Medical College (Shenzhen People's Hospital), College of Pharmacy, Jinan University, Guangzhou 510632, China.
Acta Pharm Sin B ; 13(10): 4338-4340, 2023 Oct.
Article en En | MEDLINE | ID: mdl-37799391

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Diagnostic_studies Idioma: En Revista: Acta Pharm Sin B Año: 2023 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Diagnostic_studies Idioma: En Revista: Acta Pharm Sin B Año: 2023 Tipo del documento: Article País de afiliación: China